Government Commits to Six-Month Deadline for Drug Reimbursement Decisions in Ireland (imt.ie)

• Government commits to six-month reimbursement decision timeline
• Deal includes pharmaceutical industry pricing transparency
• Positive NCPE recommendation triggers the clock

"The Irish government has committed to a new policy ensuring that decisions on drug reimbursement by the HSE are made within six months of a positive recommendation from the National Centre for Pharmacoeconomics (NCPE). This move aims to expedite patient access to innovative medicines. The commitment was made under a new deal between the government and the pharmaceutical industry, which also includes measures to improve pricing transparency and value for money. Patient advocacy groups have welcomed the step but caution that the six-month window must be consistently met to benefit patients."